Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications
Inge Kortekaas Krohn, Medya Shikhagaie, Korneliusz Golebski, et al.
Allergy (2017) Vol. 73, Iss. 4, pp. 837-850
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Type 2 immunity in the skin and lungs
Cezmi A. Akdiş, Peter D. Arkwright, Marie‐Charlotte Brüggen, et al.
Allergy (2020) Vol. 75, Iss. 7, pp. 1582-1605
Open Access | Times Cited: 420
Allergen Immunotherapy in Children User’s Guide
Montserrat Álvaro‐Lozano, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. S25, pp. 1-101
Open Access | Times Cited: 273
Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases
Ioana Agache, Cezmi A. Akdiş
Journal of Clinical Investigation (2019) Vol. 129, Iss. 4, pp. 1493-1503
Open Access | Times Cited: 258
Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response
Korneliusz Golebski, Janice A. Layhadi, Ümit Murat Şahiner, et al.
Immunity (2021) Vol. 54, Iss. 2, pp. 291-307.e7
Open Access | Times Cited: 191
Role of IL‐25, IL‐33, and TSLP in triggering united airway diseases toward type 2 inflammation
Haiyu Hong, Shumin Liao, Fenghong Chen, et al.
Allergy (2020) Vol. 75, Iss. 11, pp. 2794-2804
Open Access | Times Cited: 181
Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
Milena Sokołowska, Zuzanna Łukasik, Ioana Agache, et al.
Allergy (2020) Vol. 75, Iss. 10, pp. 2445-2476
Open Access | Times Cited: 165
Toward clinically applicable biomarkers for asthma: An EAACI position paper
Zuzana Diamant, Susanne J. H. Vijverberg, Kjell Alving, et al.
Allergy (2019) Vol. 74, Iss. 10, pp. 1835-1851
Open Access | Times Cited: 161
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid
Hideaki Morita, Terufumi Kubo, Beate Rückert, et al.
Journal of Allergy and Clinical Immunology (2019) Vol. 143, Iss. 6, pp. 2190-2201.e9
Open Access | Times Cited: 154
Recent developments and highlights in allergic rhinitis
Yifan Meng, Chengshuo Wang, Luo Zhang
Allergy (2019) Vol. 74, Iss. 12, pp. 2320-2328
Open Access | Times Cited: 147
Mechanisms of allergen-specific immunotherapy and allergen tolerance
Umut Can Küçüksezer, Cevdet Özdemir, Lacin Cevhertas, et al.
Allergology International (2020) Vol. 69, Iss. 4, pp. 549-560
Open Access | Times Cited: 140
Handling of allergen immunotherapy in the COVID‐19 pandemic: An ARIA‐EAACI statement
Ludger Klimek, Marek Jutel, Cezmi A. Akdiş, et al.
Allergy (2020) Vol. 75, Iss. 7, pp. 1546-1554
Open Access | Times Cited: 111
Biomarkers in asthma: state of the art
Angélica Tiotiu
Asthma Research and Practice (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 107
Progress in understanding hypersensitivity reactions to nonsteroidal anti‐inflammatory drugs
Inmaculada Doña, Natalia Pérez‐Sánchez, Ibón Eguíluz-Gracia, et al.
Allergy (2019) Vol. 75, Iss. 3, pp. 561-575
Open Access | Times Cited: 102
Recent developments and highlights in biomarkers in allergic diseases and asthma
Ibón Eguíluz-Gracia, Tunn Ren Tay, Mark Hew, et al.
Allergy (2018) Vol. 73, Iss. 12, pp. 2290-2305
Open Access | Times Cited: 101
Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care
Heimo Breiteneder, Zuzana Diamant, Thomas Eiwegger, et al.
Allergy (2019) Vol. 74, Iss. 12, pp. 2293-2311
Open Access | Times Cited: 96
Nasal Epithelial Barrier Integrity and Tight Junctions Disruption in Allergic Rhinitis: Overview and Pathogenic Insights
Siti Muhamad Nur Husna, Hern‐Tze Tina Tan, Norasnieda Md Shukri, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 93
Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy
Andrzej Eljaszewicz, Fiorella Ruchti, Urszula Radzikowska, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 5, pp. 1865-1877
Open Access | Times Cited: 88
Tight junctions in the development of asthma, chronic rhinosinusitis, atopic dermatitis, eosinophilic esophagitis, and inflammatory bowel diseases
Kazunari Sugita, Kenji Kabashima
Journal of Leukocyte Biology (2020) Vol. 107, Iss. 5, pp. 749-762
Closed Access | Times Cited: 85
Training the Fetal Immune System Through Maternal Inflammation—A Layered Hygiene Hypothesis
April C. Apostol, Kirk D.C. Jensen, Anna E. Beaudin
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 84
New biological treatments for asthma and skin allergies
Stefanie Eyerich, Martin Metz, Apostolos Bossios, et al.
Allergy (2019) Vol. 75, Iss. 3, pp. 546-560
Open Access | Times Cited: 83
Roles of innate lymphoid cells (ILCs) in allergic diseases: The 10-year anniversary for ILC2s
Kathleen R. Bartemes, Hirohito Kita
Journal of Allergy and Clinical Immunology (2021) Vol. 147, Iss. 5, pp. 1531-1547
Open Access | Times Cited: 75
The use of biologics in food allergy
Alessandro Fiocchi, Brian P. Vickery, Robert A. Wood
Clinical & Experimental Allergy (2021) Vol. 51, Iss. 8, pp. 1006-1018
Closed Access | Times Cited: 71
Laundry detergents and surfactants‐induced eosinophilic airway inflammation by increasing IL‐33 expression and activating ILC2s
Kyoko Saito, Keisuke Orimo, Terufumi Kubo, et al.
Allergy (2023) Vol. 78, Iss. 7, pp. 1878-1892
Closed Access | Times Cited: 40
Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months
Rik Johannes Leonardus van der Lans, Josje Janna Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2684-2697
Open Access | Times Cited: 40
Innate Type-2 Cytokines: From Immune Regulation to Therapeutic Targets
Hye Young Kim, Dongjin Jeong, Ji Hyung Kim, et al.
Immune Network (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top